Activation of nuclear factor-κB (NF-κB) often occurs in tumor cells and contributes to aggressive tumor growth and resistance to chemotherapy and radiotherapy, whereas resveratrol may downregulate NF-κB and thus increase the therapeutic efficacy by lowering the threshold for tumor cell apoptosis 93. This evidence concerns the gene NFKB1 and neoplasm.